Form 4 for RGNX REGENXBIO Inc.
Accepted 2025-06-03 00:00:00 ET · period of report 2025-05-30 · accession 0001562180-25-004347 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-03 | 2025-05-30 | RGNX | Bennett Jean | Dir | A - Grant | $0.00 | +7,768 | 19.1K | +69% | $0 |
| D | 2025-06-03 | 2025-05-30 | RGNX | Bennett Jean | Dir | A - Grant | $0.00 | +39.8K | 39.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-30 | A | A | 7,768 | $0.00 | 19,054 | D | — | — | (F1) Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer. |
| 2 | Derivative | Stock Options (Right to Buy) | 2025-05-30 | A | A | 39,815 | $0.00 | 39,815 | D | $8.85 · — to 2035-05-30 | 39,815 Common Stock | (F2) The option will vest in 12 equal monthly installments following May 30, 2025 subject to the continuous service of the optionee to the Issuer. |